Week 8 GI Flashcards
GI red flags in adult/children
- Rectal bleeding
- Weight loss
- Unexplained fever
- Anemia
- GI malignancy
- Nocturnal diarrhea (ulcerative colitis)
- Acute bowel changes in > 50 yrs old
- Bowel shape, freq, caliber of movement
- Abdominal mass
- Persistent vomiting
- Jaundice
- Dysphagia
- Ordynophagia - ongoing GERD sx or GI malignancy
- Perianal disease
- Perianal abscess or fistula
- Arthritis
- Inflammatory bowel disease
- Bilious emesis
- Jaundice
- Hematemesis
- Family hx of colon cancer
- Poor weight gain / linear growth
- Absent pubertal changes
- mass, blood in stool
Crohns disease
- Chronic inflammation of GI tract with extraintestinal sx’s
- environmental trigger
- mouth to the anus (primarily in ileocolon)
- skipped lesions, cobblestone with granulomas, fissured lesions
- “Transmural” = involves the WHOLE thickness of the colon; all layers
- “Cron skipped on the cobblestone”
Crohns on exam
- Cardinal sxs: abdominal pain, diarrhea (bleeding), fatigue, and SIGNIFICANT weight loss
- Growth failure
- Vague cramping
- Erythema nodosum, psoriasis
- Uveitis, episcleritis
- Oral ulcers/canker sore
- Decreased ROM, polyarthritis, sacrolitlits
- Rectal fissures, fistulas
crohns treatment
- mild/remission: mesalamine (aminosalicylates)
- mod-severe: corticosteroids
- immunosupppresants
- immunomodulators: infiximab (induction/maintenance)
- antibiotics: fistulas or C diff
Crohns diagnostics
- CBC, CRP, ESR, CMP (kidney function, electrolytes, glucose), vitamin b12, folate, iron
- calprotectin (confirms bowel inflammation)
- Albumin for blood loss
- Stool for ova and parasites, fecal leukocytes, C. Diff.
- Abdominal CT or MRI to monitor
- Endoscopy (cobblestone)
Ulcerative colitis
- chronic inflammation of colonic mucosa or submucosal layer in colon and rectum only
- “_Co_litis _Co_ntinuous” lesions
ulcerative colitis systemic sx’s
- fatigue, sometimes weight loss
- hematochezia (massive hemorrhage)
- stool blood/mucus
- Arthritis
- Erythema nodosum, pyoderma gangrenosum, oral ulcers
- Clubbing
- uveitis, scleritis
- Sclerosing cholangitis
- Autoimmune hemolytic anemia
- Venous and arterial thromboembolism
risk factors for colon cancer
- Age > 50
- longer duration of disease
- younger onset
- severity of inflammation
- primary sclerosis cholangitits
- Family history of colorectal cancer
- Inflammatory bowel dz
- Smoking
- Familial polyposis syndrome
if patient has 1st degree relative with colon cancer, when to start screening?
10 years prior to 1st degree relative’s diagnosis, then every 5 years thereafter
when does risk for colon cancer increase? when to screen?
- age > 50 yrs
- prior colorectal cancer
- ulcerative coliitis
- genetics
- familial polyposis syndrome
- long term cigarette smoking
- high fat high caloric diet
risk can increase 7-8 yrs after disease onset w/ risk of 0.5% per year after
- after diagnosis, screen 7-8 years post diagnosis then next 2-3 years
once in remission for IBD, more likely to relapse but also want to evaluate for
infectious causes Salmonella
- Shigella
- Campylobacter
- Clostridium difficile
- Yersinia
- Amebiasis
- Escherichia coli 0:157:H7
- STIs including Neisseria gonorrhoeae and Chlamydia trachomatis
risk factors for UC
- History of Campylobacter infection
- A first-degree relative with ulcerative colitis
- History of nontyphoid Salmonella infection
SMOKING is NOT a risk factor but it is for Crohn’s disease
Irritable bowel syndrome (IBS) diagnosis: Rome IV
Rome IV
- recurrent abdominal pain at least 1x/week x 3 months, with 2 or more of:
- with defecation
- Change in freq of stools
- change in form/look of stool (Bristol stool scale)
- symptom onset at least 6 months before diagnosis
Irritable bowel syndrome (IBS) diagnosis: Manning criteria
3 or more:
- feeling of incomplete evacuation;
- passage of mucus;
- visible abdominal distention;
- pain relief with defecation;
- looser stool at pain onset;
- more frequent stools at pain onset.
diagnosing functional bowel disorder always assumes there are NO
structural, biochemical, organic explanation for the symptoms
IBS patho
- altered gut reactivity (motility, secretion)
- hypersensitive gut with enhanced visceral perception and pain
- disordered gut-brain interaction
- other:
- altered inflammatory mediators
- altered gut serotonin regulation
- bacterial overgrowth
- genetic predisposition
IBS workup
- assess for any alarm/red flags
- if none, get stool hemoccult & CBC
- ESR, CMP, stool studies depend on clinical pic
- lactose free diet (r/o lactose intolerance)
- if > 50 & didn’t get routine colon cancer screening OR have red flags = get colonoscopy
if have IBS-C (constipation), what workup?
- therapeutic trial of fiber
- consider partial colonic obstruction or non IBS causes of dysmotility too
if have IBS-D (diarrhea), what workup?
- get stool culture, ova and parasites, celiac sprue/dz workup, or bowel biopsy (depending on clinical picture).
- If new symptom onset 45 years or older = colonoscopy to rule out microscopic colitis
- if negative, consider therapeutic trial of loperamide
if have IBS pain predominant, what workup?
- get abdominal x-ray
- if negative for small bowel obstruction (SBO), consider therapeutic trial of an antispasmodic medication
IBS treatment for mild sx’s
IBS med treatment for moderate to severe sx’s for IBS-C:
- increased dietary fiber (25g/day) – soluble fiber > insoluble
- polyethylene glycol (MiraLAX) – osmotic laxative
- lubiprostone – chloride channel activator that increases intestinal fluid secretion to improve intestinal transit5
- linaclotide– guanylate cyclase c agonist; increased intestinal chloride and bicarbonate secretion leads to acceleration of intestinal transit, may also have analgesic effect
- plecanatide – guanylate cyclase c agonist
IBS med treatment for moderate to severe sx’s for IBS-D:
- loperamide – antidiarrheal, inhibits peristalsis; PRN
- alosetron – 5-HT receptor antagonist, decreases colonic motility. Approved for use in women with severe IBS-D who have failed conservative treatment for greater than 6 months. Adverse events include ischemic colitis and severe constipation.
- eluxadoline – mu-opioid receptor agonist + delta opioid receptor antagonist + kappa opioid receptor agonist; reduces visceral pain and diarrhea with constipation side effect. Avoid use in patients who do not have a gallbladder, carries FDA warning for risk of pancreatitis.
IBS med treatment for moderate to severe sx’s for IBS pain predominant
- hyoscyamine, dicyclomine, peppermint oil – antispasmodics that reduce smooth muscle contractions and visceral hypersensitivity
- antidepressants (TCAs, SSRIs )
- antibiotic (Rifaximin) – alters gut microbiota; given as 2-week course
- probiotics